The Clorox Company filed an 8-K announcing on Oct. 29, 2026 that its Board of Directors has appointed Fabian Garcia as CEO, effective Jan. 5, 2027, succeeding Linda Rendle, who will step down for health reasons.
Key Highlights
- New CEO appointed: Fabian Garcia will assume the CEO role at Clorox on Jan. 5, 2027, following a comprehensive search, according to the filing.
- Current CEO departing: Linda Rendle, who announced in May that she would step down for health reasons, will remain as chair and CEO until Garcia assumes the role, then step down as CEO and as a director.
- Advisory period: Rendle will continue in an advisory capacity through April 2, 2027 to help ensure a smooth transition, the filing disclosed.
- Board chair change: Matthew Shattock, the company's lead independent director and former Board chair, will become independent chair when Garcia joins.
- Garcia's current role: Garcia currently serves as president of Unilever Personal Care and is a member of the Unilever Leadership Executive team, with more than four decades of global consumer products leadership experience.
- Prior CEO experience: Before Unilever, Garcia served as CEO of Revlon and as chief operating officer for Global Innovation and Growth at Colgate-Palmolive, per the filing.
- Board membership: Garcia will join the Clorox Board of Directors at the time of his appointment as CEO, the filing stated.
Clorox Board Appoints Garcia as CEO After Comprehensive Search
According to the filing, The Clorox Company (NYSE:CLX) announced that its Board of Directors appointed Fabian Garcia as CEO, effective Jan. 5, 2027. Garcia succeeds Linda Rendle, who disclosed in May that she would step down as CEO for health reasons. Rendle will continue to serve as chair and CEO until Garcia assumes the CEO role, after which she will step down from both positions and from the Board of Directors.
The filing noted that Garcia currently serves as president of Unilever Personal Care and is a member of the Unilever Leadership Executive team. Since joining Unilever in 2020, he has held several senior leadership roles, including president of Unilever North America. Prior to Unilever, Garcia served as CEO of Revlon and as chief operating officer for Global Innovation and Growth at Colgate-Palmolive. Earlier in his career, the filing stated, he held a series of global leadership roles at Procter and Gamble. Garcia currently serves on the Board of Directors of Wells Fargo, having previously served on the boards of Kimberly-Clark and Arrow Electronics.
At the time of Garcia's appointment, Matthew Shattock, described in the filing as the company's lead independent director and former Board chair, will resume the position of independent chair. Clorox also noted it will report first-quarter fiscal year 2027 earnings results on Monday, Nov. 2, with Rendle and Chief Financial Officer Luc Bellet participating in an earnings call with analysts.
What Was Disclosed
Clorox disclosed the appointment of Fabian Garcia as CEO effective Jan. 5, 2027, the planned leadership transition from Linda Rendle, Rendle's advisory role through April 2, 2027, and the resumption of Matthew Shattock as independent chair upon Garcia joining the Board.



Please wait processing your request...